Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
220.3 INR | +4.78% | -5.17% | -23.19% |
Sales 2022 | 1.37B 16.45M | Sales 2023 | 2.39B 28.62M | Capitalization | 58.2B 698M |
---|---|---|---|---|---|
Net income 2022 | -2.03B -24.38M | Net income 2023 | -2.23B -26.68M | EV / Sales 2022 | 59.3 x |
Net Debt 2022 | 663M 7.95M | Net cash position 2023 | 3.87B 46.36M | EV / Sales 2023 | 22.8 x |
P/E ratio 2022 |
-38.4
x | P/E ratio 2023 |
-22.9
x | Employees | 407 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25.38% |
Latest transcript on Sun Pharma Advanced Research Company Limited
1 day | +4.78% | ||
1 week | -5.17% | ||
Current month | -5.17% | ||
1 month | -49.20% | ||
3 months | -39.08% | ||
6 months | -6.61% | ||
Current year | -23.19% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 14-04-23 | |
Chetan Rajpara
DFI | Director of Finance/CFO | - | 17-01-31 |
Chairman | 68 | 06-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 06-02-28 | |
Director/Board Member | 67 | 06-02-28 | |
Director/Board Member | 70 | 14-10-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 0 M€ | +3.22% | - | |
0.00% | 0 M€ | +3.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 220.3 | +4.78% | 1,178,205 |
24-05-07 | 210.2 | -1.87% | 2,037,804 |
24-05-06 | 214.2 | -4.99% | 2,266,070 |
24-05-03 | 225.5 | -4.99% | 2,436,000 |
24-05-02 | 237.4 | +2.17% | 12,162,580 |
Delayed Quote NSE India S.E., May 08, 2024 at 07:40 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-23.19% | 818M | |
+32.95% | 700B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B | |
-1.81% | 157B |
- Stock Market
- Equities
- SPARC Stock